Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

4,100.00p
   
  • Change Today:
    -90.00p
  • 52 Week High: 4,500.00
  • 52 Week Low: 3,800.00
  • Currency: UK Pounds
  • Shares Issued: 5.21m
  • Volume: 2,251
  • Market Cap: £213.58m

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
62.91% above the market average62.91% above the market average62.91% above the market average62.91% above the market average62.91% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
1yr Revenue Growth
50.91% above the market average50.91% above the market average50.91% above the market average50.91% above the market average50.91% above the market average
5.88% above the sector average5.88% above the sector average5.88% above the sector average5.88% above the sector average5.88% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
12.31% below the market average12.31% below the market average12.31% below the market average12.31% below the market average12.31% below the market average
55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average
1yr DPS Growth
48.18% above the market average48.18% above the market average48.18% above the market average48.18% above the market average48.18% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
43.04% above the market average43.04% above the market average43.04% above the market average43.04% above the market average43.04% above the market average
18.75% above the sector average18.75% above the sector average18.75% above the sector average18.75% above the sector average18.75% above the sector average
Price Book Ratio
92.04% below the market average92.04% below the market average92.04% below the market average92.04% below the market average92.04% below the market average
67.35% below the sector average67.35% below the sector average67.35% below the sector average67.35% below the sector average67.35% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
22.8% below the market average22.8% below the market average22.8% below the market average22.8% below the market average22.8% below the market average
32.20% above the sector average32.20% above the sector average32.20% above the sector average32.20% above the sector average32.20% above the sector average
Price Chg 3m
55.17% below the market average55.17% below the market average55.17% below the market average55.17% below the market average55.17% below the market average
5.08% below the sector average5.08% below the sector average5.08% below the sector average5.08% below the sector average5.08% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
11.23% below the market average11.23% below the market average11.23% below the market average11.23% below the market average11.23% below the market average
43.86% above the sector average43.86% above the sector average43.86% above the sector average43.86% above the sector average43.86% above the sector average
Momentum 20
77.42% below the market average77.42% below the market average77.42% below the market average77.42% below the market average77.42% below the market average
82.46% above the sector average82.46% above the sector average82.46% above the sector average82.46% above the sector average82.46% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
80.91% above the market average80.91% above the market average80.91% above the market average80.91% above the market average80.91% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
ROCE
77.50% above the market average77.50% above the market average77.50% above the market average77.50% above the market average77.50% above the market average
68.42% above the sector average68.42% above the sector average68.42% above the sector average68.42% above the sector average68.42% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
94.24% above the market average94.24% above the market average94.24% above the market average94.24% above the market average94.24% above the market average
92.00% above the sector average92.00% above the sector average92.00% above the sector average92.00% above the sector average92.00% above the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
33.04% below the market average33.04% below the market average33.04% below the market average33.04% below the market average33.04% below the market average
Sector averageSector averageSector averageSector averageSector average
Operating Profit Loss
41.44% above the market average41.44% above the market average41.44% above the market average41.44% above the market average41.44% above the market average
61.54% above the sector average61.54% above the sector average61.54% above the sector average61.54% above the sector average61.54% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
26.97% below the market average26.97% below the market average26.97% below the market average26.97% below the market average26.97% below the market average
18.37% below the sector average18.37% below the sector average18.37% below the sector average18.37% below the sector average18.37% below the sector average
Cash
7.45% below the market average7.45% below the market average7.45% below the market average7.45% below the market average7.45% below the market average
11.54% below the sector average11.54% below the sector average11.54% below the sector average11.54% below the sector average11.54% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 4,100.00p
Change Today -90.00p
% Change -2.15 %
52 Week High 4,500.00
52 Week Low 3,800.00
Volume 2,251
Shares Issued 5.21m
Market Cap £213.58m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
86.55% below the market average86.55% below the market average86.55% below the market average86.55% below the market average86.55% below the market average
80.77% below the sector average80.77% below the sector average80.77% below the sector average80.77% below the sector average80.77% below the sector average
Price Trend
61.4% below the market average61.4% below the market average61.4% below the market average61.4% below the market average61.4% below the market average
49.15% below the sector average49.15% below the sector average49.15% below the sector average49.15% below the sector average49.15% below the sector average
Income Not Available
Growth
77.58% above the market average77.58% above the market average77.58% above the market average77.58% above the market average77.58% above the market average
16.67% above the sector average16.67% above the sector average16.67% above the sector average16.67% above the sector average16.67% above the sector average

Bioventix Dividends

  Latest Previous
  1st Interim Special
Ex-Div 08-Apr-21 29-Oct-20
Paid 23-Apr-21 13-Nov-20
Amount 43.00p 53.00p

Trades for 23-Jun-2021

Time Volume / Share Price
15:53 5 @ 4,100.00p
15:46 9 @ 4,065.00p
15:42 109 @ 4,050.00p
15:39 105 @ 4,050.00p
15:32 371 @ 4,050.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page